Antineoplastic Drugs: Occupational Exposure and Side Effects

Anonymous (2012). Antineoplastic drugs: Hazardous, handle with care. ONA (Ontario Nurses Association) – Local 100 Newsletter, December, 7–13.Search in Google Scholar

Buschini, A., Villarini, M., Feretti, D., Mussi, F., Dominici, L., Zerbini, I., Moretti, M., Ceretti, E., Bonfiglioli, R., Carrieri, M., Gelatti, U., Rossi, C., Monarca, S., Poli, P. (2013). Multicentre study for the evaluation of mutagenic/carcinogenic risk in nurses exposed to antineoplastic drugs: Assessment of DNA damage. Occup. Environ. Med.,70 (11), 789–794.10.1136/oemed-2013-10147524143019Search in Google Scholar

Gómez-Olivįn, L. M., Miranda-Mendoza, G. D., Cabrera-Galeana, P. A., Galar-Martínez, M., Islas-Flores, H., SanJuan-Reyes, N., Neri-Cruz, N., García-Medina, S. (2014). Oxidative stress induced in nurses by exposure to preparation and handling of antineoplastic drugs in Mexican hospitals: A multicentric study. Oxid. Med. Cell. Longevity,2014, 7.10.1155/2014/858604395641924719678Search in Google Scholar

Keat, C. H., Sooaid, N. S., Yun, C. Y., Sriraman, M. (2013). Improving safety-related knowledge, attitude and practices of nurses handling cytotoxic anticancer drug: Pharmacists’ experience in a general hospital, Malaysia. Asian Pacif. J. Cancer Prevent., 14 (1), 69–73.10.7314/APJCP.2013.14.1.69Search in Google Scholar

Lawson, C. C., Rocheleau, C. M., Whelan, E. A., Lividoti Hibert, E. N., Grajewski, B., Spiegelman, D., Rich-Edwards, J. W. (2012). Occupational exposures and spontaneous abortion. Amer. J. Obstetrics Gynecol., 206 (4), e1–e8.Search in Google Scholar

Momeni, M., Danaei, M., Askarian, M. (2013). How do nurses manage their occupational exposure to cytotoxic drugs? A descriptive survey in chemotherapy settings, Shiraz, Iran. Int. J. Occup. Environ. Med., 4 (2), 102–106.Search in Google Scholar

Anonymous (2014). NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2014. U.S. Department of Health and Human Services Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2014-138.Search in Google Scholar

Shahrasbi, A. A., Afshar, M., Shokraneh, F., Monji, F., Noroozi, M., Ebrahimi-Khojin, M., Madani, S. F., Ahadi-Barzoki, M., Rajabi, M. (2014). Risks to health professionals from hazardous drugs in Iran: A pilot study of understanding of healthcare team to occupational exposure to cytotoxics. Exper. Clin. Sci. Int. Online J. Adv. Sci.,13, 491–501.Search in Google Scholar

Villarini, M., Dominici, L., Fatigoni, C., Muzi, G., Monarca, S., Moretti, M. (2012). Biological effect monitoring in peripheral blood lymphocytes from subjects occupationally exposed to antineoplastic drugs: Assessment of micronuclei frequency. J. Occup. Health, 54 (9), 405–415.10.1539/joh.12-0038-OA22986622Search in Google Scholar

Yu Wen, H., Le, J., Mei, Bian, Z. Quan, Z., Xiao Feng, Y., Xu Dong, H., Ying, Z., Ji Liang, H. (2012). An investigation of oxidative DNA damage in pharmacy technicians exposed to antineoplastic drugs in two Chinese hospitals using the urinary 8-OHdG assay. Biomed. Environ. Sci.,25 (1), 109–116.Search in Google Scholar